These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19753452)

  • 1. Chagas disease centennial anniversary celebration: historical overview and prospective proposals aiming to maintain vector control and improve patient prognosis--a permanent challenge.
    Lannes-Vieira J; Soeiro Mde N; Corrêa-Oliveira R; Araújo-Jorge TC
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():5-7. PubMed ID: 19753452
    [No Abstract]   [Full Text] [Related]  

  • 2. The evolution of Chagas disease (American trypanosomiasis) control after 90 years since Carlos Chagas discovery.
    Dias J; Schofield C
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():103-21. PubMed ID: 10677697
    [No Abstract]   [Full Text] [Related]  

  • 3. Andean subregional Chagas disease area and the Andean initiative of Chagas disease.
    Salvatella R
    Mem Inst Oswaldo Cruz; 2007 Oct; 102 Suppl 1():39-40. PubMed ID: 17906804
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of Chagas disease screening programs and control programs: historical perspective.
    Dias JC
    Glob Heart; 2015 Sep; 10(3):193-202. PubMed ID: 26407516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological, social, and control determinants of Chagas disease in Central America and Mexico--group discussion.
    Zeledón R; Ponce C; Méndez-Galván JF
    Mem Inst Oswaldo Cruz; 2007 Oct; 102 Suppl 1():45-6. PubMed ID: 17906806
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress toward elimination of Chagas' disease transmission in Argentina.
    Bull Pan Am Health Organ; 1996 Mar; 30(1):84-6. PubMed ID: 8919731
    [No Abstract]   [Full Text] [Related]  

  • 7. Elimination of vector-borne transmission of Chagas disease.
    Silveira A; Vinhaes M
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():405-11. PubMed ID: 10677766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chagas disease in Brazil].
    Vinhaes MC; Dias JC
    Cad Saude Publica; 2000; 16 Suppl 2():7-12. PubMed ID: 11119316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of improved methodologies and indicators for monitoring and evaluation of Chagas' disease vector control operations.
    Nelson MJ
    Rev Argent Microbiol; 1988; 20(1 Suppl):91-5. PubMed ID: 3138740
    [No Abstract]   [Full Text] [Related]  

  • 10. The effectiveness of design and construction materials in Chagas' disease vector control.
    Cedillos RA
    Rev Argent Microbiol; 1988; 20(1 Suppl):53-7. PubMed ID: 3138734
    [No Abstract]   [Full Text] [Related]  

  • 11. Ten years of Chagas disease research: Looking back to achievements, looking ahead to challenges.
    Dumonteil E; Herrera C
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005422. PubMed ID: 28426735
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of new insecticides and synergistic formulations for the Chagas' disease vector control.
    Zerba E
    Rev Argent Microbiol; 1988; 20(1 Suppl):25-31. PubMed ID: 3138729
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fenitrothion (OMS-43) in the control of Triatoma infestans, the vector of Chagas disease in Argentina].
    Cichero JA; Gualtieri JA; Vaez R; Rios CH; Carcavallo RU
    Ann Soc Belg Med Trop; 1985; 65 Suppl 1():181-5. PubMed ID: 3931583
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemical control of Chagas' disease vectors: transfer of technology from research to practical control.
    Gilbert B
    Rev Argent Microbiol; 1988; 20(1 Suppl):49-52. PubMed ID: 3138733
    [No Abstract]   [Full Text] [Related]  

  • 15. On bugs and bias: improving Chagas disease control assessment.
    Abad-Franch F; Diotaiuti L; Gurgel-Gonçalves R; Gürtler RE
    Mem Inst Oswaldo Cruz; 2014 Feb; 109(1):125-30. PubMed ID: 24809110
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening and structure-activity relationships of synthetic juvenile hormone analogues for Panstrongylus megistus, a primary vector of Chagas' disease in Brazil.
    Pinchin R; de Oliveira Filho AM; Figueiredo MJ; Muller CA; Gilbert B; Szumlewicz AP; Benson WW
    J Econ Entomol; 1978 Dec; 71(6):950-5. PubMed ID: 110859
    [No Abstract]   [Full Text] [Related]  

  • 17. American trypanosomiasis. An historical and a human lesson.
    Guerra F
    J Trop Med Hyg; 1970 Apr; 72(4):83-104 contd. PubMed ID: 4987954
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of Chagas' disease vectors.
    Schofield CJ
    Br Med Bull; 1985 Apr; 41(2):187-94. PubMed ID: 3928022
    [No Abstract]   [Full Text] [Related]  

  • 19. [The beginning of the disease].
    Prata A; Dias JC; Coura JR
    Rev Soc Bras Med Trop; 2011; 44 Suppl 2():6-11. PubMed ID: 21584351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of peridomestic environmental management for the control of the vectors of Chagas' disease.
    Bos R
    Rev Argent Microbiol; 1988; 20(1 Suppl):58-62. PubMed ID: 3138735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.